Ballantyne Charles Evan 4
4 · Gain Therapeutics, Inc. · Filed Apr 12, 2023
Insider Transaction Report
Form 4
Ballantyne Charles Evan
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-04-10+100,000→ 100,000 totalExercise: $4.79Exp: 2033-04-10→ Common Stock (100,000 underlying) - Award
Restricted Stock Units
2023-04-10+50,000→ 50,000 total→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]The shares underlying the option shall vest 25% on April 10, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F3]The RSUs vest upon the board of directors' certification of the Issuer's share price reaching $10.00 per share based on the 10-day volume weighted average share price, subject to Reporting Person's continuous service through such vesting date.